Alfredo A. Hinay Jr

Dr. Alfredo A. Hinay Jr

Division of Systems Virology, The University of Tokyo, Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2024 in EBioMedicine
Verified
Journal Article
Open access
SFShigeru Fujita
Shigeru Fujita
APArnon Plianchaisuk
Arnon Plianchaisuk
SDSayaka Deguchi
Sayaka Deguchi
HIHayato Ito
Hayato Ito
NNNaganori Nao
Naganori Nao
KSKei Sato
Kei Sato
Although several SARS-CoV-2-related coronaviruses (SC2r-CoVs) were discovered in bats and pangolins, the differences in virological characteristics between SARS-CoV-2 and SC2r-CoVs remain poorly understood. Recently, BANAL-20-236 (B236) was isolated from a rectal swab of Malayan horseshoe bat and was found to lack a furin cleavage site (FCS) in the spike (S) protein. The comparison of its virological characteristics with FCS-deleted SARS-CoV-2 (SC2ΔFCS) has not been conducted yet. We prepared human induced pluripotent stem cell (iPSC)-derived airway and lung epithelial cells and colon organoids as human organ-relevant models. B236, SARS-CoV-2, and artificially generated SC2ΔFCS were used for viral experiments. To investigate the pathogenicity of B236 in vivo, we conducted intranasal infection experiments in hamsters. In human iPSC-derived airway epithelial cells, the growth of B236 was significantly lower than that of the SC2ΔFCS. A fusion assay showed that the B236 and SC2ΔFCS S proteins were less fusogenic than the SARS-CoV-2 S protein. The infection experiment in hamsters showed that B236 was less pathogenic than SARS-CoV-2 and even SC2ΔFCS. Interestingly, in human colon organoids, the growth of B236 was significantly greater than that of SARS-CoV-2. Compared to SARS-CoV-2, we demonstrated that B236 exhibited a tropism toward intestinal cells rather than respiratory cells. Our results are consistent with a previous report showing that B236 is enterotropic in macaques. Altogether, our report strengthens the assumption that SC2r-CoVs in horseshoe bats replicate primarily in the intestinal tissues rather than respiratory tissues. This study was supported in part by AMED ASPIRE (JP23jf0126002, to Keita Matsuno, Kazuo Takayama, and Kei Sato); AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers "UTOPIA" (JP223fa627001, to Kei Sato), AMED SCARDA Program on R&D of new generation vaccine including new modality application (JP223fa727002, to Kei Sato); AMED SCARDA Hokkaido University Institute for Vaccine Research and Development (HU-IVReD) (JP223fa627005h0001, to Takasuke Fukuhara, and Keita Matsuno); AMED Research Program on Emerging and Re-emerging Infectious Diseases (JP21fk0108574, to Hesham Nasser; JP21fk0108493, to Takasuke Fukuhara; JP22fk0108617 to Takasuke Fukuhara; JP22fk0108146, to Kei Sato; JP21fk0108494 to G2P-Japan Consortium, Keita Matsuno, Shinya Tanaka, Terumasa Ikeda, Takasuke Fukuhara, and Kei Sato; JP21fk0108425, to Kazuo Takayama and Kei Sato; JP21fk0108432, to Kazuo Takayama, Takasuke Fukuhara and Kei Sato; JP22fk0108534, Terumasa Ikeda, and Kei Sato; JP22fk0108511, to Yuki Yamamoto, Terumasa Ikeda, Keita Matsuno, Shinya Tanaka, Kazuo Takayama, Takasuke Fukuhara, and Kei Sato; JP22fk0108506, to Kazuo Takayama and Kei Sato); AMED Research Program on HIV/AIDS (JP22fk0410055, to Terumasa Ikeda; and JP22fk0410039, to Kei Sato); AMED Japan Program for Infectious Diseases Research and Infrastructure (JP22wm0125008 to Keita Matsuno); AMED CREST (JP21gm1610005, to Kazuo Takayama; JP22gm1610008, to Takasuke Fukuhara; JST PRESTO (JPMJPR22R1, to Jumpei Ito); JST CREST (JPMJCR20H4, to Kei Sato); JSPS KAKENHI Fund for the Promotion of Joint International Research (International Leading Research) (JP23K20041, to G2P-Japan Consortium, Keita Matsuno, Takasuke Fukuhara and Kei Sato); JST SPRING (JPMJSP2108 to Shigeru Fujita); JSPS KAKENHI Grant-in-Aid for Scientific Research C (22K07103, to Terumasa Ikeda); JSPS KAKENHI Grant-in-Aid for Scientific Research B (21H02736, to Takasuke Fukuhara); JSPS KAKENHI Grant-in-Aid for Early-Career Scientists (22K16375, to Hesham Nasser; 20K15767, to Jumpei Ito); JSPS Core-to-Core Program (A. Advanced Research Networks) (JPJSCCA20190008, to Kei Sato); JSPS Research Fellow DC2 (22J11578, to Keiya Uriu); JSPS Research Fellow DC1 (23KJ0710, to Yusuke Kosugi); JSPS Leading Initiative for Excellent Young Researchers (LEADER) (to Terumasa Ikeda); World-leading Innovative and Smart Education (WISE) Program 1801 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to Naganori Nao); Ministry of Health, Labour and Welfare (MHLW) under grant 23HA2010 (to Naganori Nao and Keita Matsuno); The Cooperative Research Program (Joint Usage/Research Center program) of Institute for Life and Medical Sciences, Kyoto University (to Kei Sato); International Joint Research Project of the Institute of Medical Science, the University of Tokyo (to Terumasa Ikeda and Takasuke Fukuhara); The Tokyo Biochemical Research Foundation (to Kei Sato); Takeda Science Foundation (to Terumasa Ikeda and Takasuke Fukuhara); Mochida Memorial Foundation for Medical and Pharmaceutical Research (to Terumasa Ikeda); The Naito Foundation (to Terumasa Ikeda); Hokuto Foundation for Bioscience (to Tomokazu Tamura); Hirose Foundation (to Tomokazu Tamura); and Mitsubishi Foundation (to Kei Sato).

9 September 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
AJAlfredo A. Hinay Jr
Alfredo A. Hinay Jr
SKSosuke Kakee
Sosuke Kakee
SKSeiji Kageyama
Seiji Kageyama
ATAkeno Tsuneki-Tokunaga
Akeno Tsuneki-Tokunaga
WPWaldy Y. Perdana
Waldy Y. Perdana
KKKyosuke Kanai
Kyosuke Kanai
In a previous study, we described the diverse growth capabilities of circulating seasonal influenza A viruses (IAVs) with low to high viral copy numbers in vitro. In this study, we analyzed the cause of differences in growth capability by evaluating pro-inflammatory cytokines (TNF-α, IL-6, IFN-β) and antiviral interferon-stimulated genes (ISG-15, IFIM1, and TRIM22). A549 cells (3.0 × 105 cells) were inoculated with circulating seasonal IAV strains and incubated for 6 and 24 h. In cells inoculated for 6 h, IAV production was assessed using IAV-RNA copies in the culture supernatant and cell pellets to evaluate gene expression. At 24 h post-infection, cells were collected for IFN-β and ISG-15 protein expression. A549 cells inoculated with seasonal IAV strains with a high growth capability expressed lower levels of IFN-β and ISGs than strains with low growth capabilities. Moreover, suppression of the JAK/STAT pathway enhanced the viral copies of seasonal IAV strains with a low growth capability. Our results suggest that the expression of ISG-15, IFIM1, and TRIM22 in seasonal IAV-inoculated A549 cells could influence the regulation of viral replication, indicating the existence of strains with high and low growth capability. Our results may contribute to the development of new and effective therapeutic strategies to reduce the risk of severe influenza infections.

1 January 2019 in Journal of the International Association of Providers of AIDS Care (JIAPAC)
Verified
Journal Article
Open access
PDF file
SKSeiji Kageyama
Seiji Kageyama
AJAlfredo A. Hinay Jr
Alfredo A. Hinay Jr
ETElizabeth Freda Omengan Telan
Elizabeth Freda Omengan Telan
GSGenesis May Jopson Samonte
Genesis May Jopson Samonte
PLPrisca Susan Agustin Leano
Prisca Susan Agustin Leano
KKKyosuke Kanai
Kyosuke Kanai
Although drug-resistant HIV variants are considered to be less fit than drug-susceptible viruses, replication competence of these variants harbored by patients has not yet been elucidated in detail. We herein assessed the replication competence of strains obtained from individuals receiving antiretroviral therapy. Among 11 306 participants in a drug resistance surveillance in the Philippines, 2629 plasma samples were obtained from individuals after a 12-month treatment with zidovudine (ZDV)/lamivudine (3TC)/nevirapine (NVP). The replication competence of HIV isolates was then assessed by reinoculation into seronegative peripheral blood mononuclear cells in the absence of drugs in vitro. The drug resistance rate was estimated to be 9.2%. Drug-resistant strains were still a minority of closely related strains in a phylogenetic cluster. Among the available 295 samples, 37 HIV strains were successfully isolated. Progeny viruses were produced at a wide range (5.1 × 106 to 3.4 × 109 copies/mL) in primary culture of peripheral blood mononuclear cells. The viral yields were higher than the corresponding plasma viral load (1300 to 3.4 × 106 copies/mL) but correlated with those ( r = 0.4). These results suggest that strains with higher intrinsic replication competence are one of the primary targets of newly selected drugs at the increasing phase of the plasma viral load during antiretroviral therapy.

AJAlfredo A. Hinay Jr
Alfredo A. Hinay Jr
MMMarielle A. Mamalintaw
Marielle A. Mamalintaw
JDJoulei Mei L. Damasin
Joulei Mei L. Damasin
BDBai Jana Shamera A. Dilangalen
Bai Jana Shamera A. Dilangalen
BMBrent Adrian S. Montinola
Brent Adrian S. Montinola
ADAvee Joy B. Dayaganon
Avee Joy B. Dayaganon
Background/Objectives: Tuberculosis (TB) remains a major public health challenge in Davao City, Philippines, with persistent issues in both disease burden and treatment outcomes. Understanding the risk factors for TB and its unsuccessful treatment is essential for guiding effective interventions. This study aimed to evaluate the association of sociodemographic and clinical factors with TB occurrence and to identify predictors of unsuccessful TB treatment outcomes among patients in Davao City. Methods: A retrospective cohort study was conducted using data from 521 patients diagnosed with drug-susceptible TB at Davao Chest Center between January 2021 and May 2024. The sociodemographic and clinical profiles of the patients were described using descriptive statistics. Chi-square tests were used to assess the associations between sociodemographic and clinical variables with TB risk and treatment outcomes. Results: The patient cohort was predominantly aged 31–50 years (n = 201, 38.58%), male (n = 284, 54.51%), and married (n = 285, 54.70%), with most residing in Districts I and II (n = 98, 38% each), and had no previous TB treatment (n = 344, 66.03%). Among the 456 patients assessed for comorbidities, 56.14% (n = 256) had at least one comorbidity. Evaluation of the risk factors for TB occurrence among the study population revealed that comorbidity status was not significantly associated with an increased risk of TB diagnosis (p = 0.682). However, among patients diagnosed with TB, the presence of comorbidities was significantly associated with unsuccessful treatment outcomes (p = 0.003). Conclusions: Although sociodemographic factors did not significantly influence TB risk or treatment outcomes, the presence of comorbidities was a significant predictor of unsuccessful TB treatment. These findings highlight the importance of integrating comorbidity management with TB care to improve treatment success in high-burden urban settings.

24 September 2024 in Dialogues in Health
Verified
Journal Article
Open access
REReigner Jay B. Escartin
Reigner Jay B. Escartin
RSRvin John T. Servillon
Rvin John T. Servillon
JLJesille Mae A. Legarta
Jesille Mae A. Legarta
SAStephanie Kate G. Arriola
Stephanie Kate G. Arriola
PBPrincess Faiqah A. Brahim
Princess Faiqah A. Brahim
AJAlfredo A. Hinay Jr
Alfredo A. Hinay Jr
Antiretroviral therapy (ART) has significantly improved the prognosis and quality of life of HIV/AIDS patients. However, ART success is greatly influenced by patient adherence to the treatment regimens. This study aimed to assess the association between patient adherence to ART and the treatment success rate among antiretroviral-naïve patients in Davao City, Philippines. This study utilized a 10-year retrospective cohort design, including 517 antiretroviral-naïve patients from an HIV treatment hub in Davao City, the Philippines. Using strict inclusion criteria, 183 antiretroviral-naïve patients were analyzed. The study found significant associations between the type of ART (p = 0.011) and the timing of ART initiation (p = 0.006) with both patient adherence and the ART success rate. Specifically, patients who achieved sustained viral suppression were predominantly those who initiated ART early, with 71.6 % (n = 131) of them prescribed a regimen consisting of 2 NRTIs and 1 NNRTI. Moreover, 73.8 % of patients demonstrated good adherence (<50 HIV copies/mL). Importantly, patient adherence to ART was strongly correlated with treatment success rate. This study highlights the significance of adherence to antiretroviral therapy (ART) for successful treatment outcomes among antiretroviral-naïve patients living with HIV/AIDS. Early initiation of ART and consistent adherence to treatment regimens are essential for achieving sustained viral suppression and improving treatment effectiveness.

31 December 2024 in Food Science and Preservation
Verified
Journal Article
Open access
PDF file
KDKimberly Marie S. Develos
Kimberly Marie S. Develos
KNKaizen John O. Nerio
Kaizen John O. Nerio
KFKyla Diane C. Fuentes
Kyla Diane C. Fuentes
ALAlfea B. Lanaban
Alfea B. Lanaban
KMKaye Jara B. Mapundo
Kaye Jara B. Mapundo
AJAlfredo A. Hinay Jr
Alfredo A. Hinay Jr
The misuse of antibiotics, including tetracycline, is a significant issue in veterinary medicine because of their widespread use, leading to antibiotic residues in animal tissues. Residues pose health risks to consumers and promote antimicrobial resistance. This study aimed to detect tetracycline residues in retail pork meat and liver samples from selected public markets in Davao city. A total of 146 pork samples were tested, comprising 74 meat and 72 liver samples. Detection was performed using enzyme-linked immunosorbent assay (ELISA). The results showed that all samples were positive for tetracycline residue with a mean concentration level of 67.12±11.29 ng/g for meat samples and 74.01±16.43 ng/g in liver samples. However, none reached or exceeded the maximum residue levels of 200 ng/g and 600 ng/g for meat and liver, respectively. Liver samples had significantly higher mean tetracycline concentrations than meat samples from three public markets in Davao city. The detected levels were within the regulatory limits, and the significant difference between liver and meat samples highlights the need for continued monitoring of antibiotic residues in different animal tissues.